Kabbalist Rav Berg explained some twenty years ago that the 42 Letter Name of God, one of the technologies used in the creation of the universe, has the power to revert our cells back to a stem cell state. This Name of God then reprograms the stem cells back into healthy new adult cells for the particular organ or body part in need of repair, regeneration and restoration. Of course, Kabbalah’s technology operates on the level of consciousness. However, as we progress, the ancient Kabbalists tell us that science will eventually confirm in the 1 percent physical reality, that which has been accomplished in the 99 percent level of reality — the dimensions of consciousness.
Recently, the Wall Street Journal reported that instead of destroying embryos to harness stem cells, researchers were able to coax adult cells back into their embryonic state.
These are the very words Rav Berg used each and every day, some twenty years ago, during the meditation on the 42 Letter Name, known in Hebrew as Ana Bekoakh.
Specifically, the third stanza, featuring the Hebrew letters Yod, Cuff, Shin, are used to reprogram our cells back into an embryonic stem cell state to cleanse and purify them. We then return these stem cells back into adult cells, free of the negativity that was created from self-interest, reactive and selfish consciousness.
Science has just accomplished the same thing.
This is yet another sign of what Kabbalah has been accomplishing on the 99 percent level.
Each day that you do the meditations on the 42 Letter Name, with as much certainty as possible, you are empowering science and technology to prove what we are accomplishing on the higher dimension of consciousness.
Yes, there will come a time when we won’t need physical instruments to perform such tasks. The power of our minds, once free of all ego and self-interest, will accomplish of this through the technology of the Names of God, the letter sequences that are the interface between the physical and spiritual worlds.
Below is an excerpt from the Wall Street Journal article.
A Massachusetts biotechnology company said it expects as early as Friday to start the process for regulatory approval of what would be the first human trial involving stem cells created by reprogramming adult cells back to an embryonic-like state.
Researchers have been experimenting with treatments derived from stem cells, which can grow into other cell types or tissues. But such cells are typically obtained by destroying human embryos, a controversial practice. Scientists are experimenting with other types of stem cells derived from bone marrow or umbilical cord blood, but such cells are limited in the types of cells they can grow into.
The newer approach involves reprogramming mature cells, typically from the skin, without the need to destroy embryos. Two of the researchers who developed the process shared a Nobel Prize this year for the work.